Abstract: Novel splice variant nucleic acid sequences. The novel splice variants and their nucleic acid sequences according to the present invention may optionally be used for diagnosis of a variant-detectable disease as described herein.

Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.

Abstract: Novel markers for colon cancer that are both sensitive and accurate. These markers are overexpressed in colon cancer specifically, as opposed to normal colon tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of colon cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between colon cancer and non-cancerous states.

Abstract: One non-limiting embodiment of the invention comprises the steps of accessing at least two impact analysis repositories, calculating a combined impact analysis repository from the at least two impact analysis repositories, and utilizing the combined impact analysis repository for supplying better quality impact analysis results.

Abstract: Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.

Abstract: Disclosed are peptide ligands for G-protein coupled receptors that are useful for treating disorders associated with G-protein coupled receptor activation.

Abstract: Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.

Abstract: A system and method for analyzing a computer program comprising a first multiplicity of elements having a second multiplicity of functional relationships defined therebetween, the first multiplicity of elements including interface elements and non-interface elements, the method comprising reading source code, finding at least selected interface elements in the source code, and identifying, and displaying to a user, only those functional relationships which are defined between the selected interface elements.

Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.

Abstract: Methods comprising the steps of receiving a code to be analyzed; running a flow analysis of the received code; running a backward and/or forward analysis, whereby the analysis returns at least one input statement; selecting at least one externally-visible statement from the returned list of statements; associating each externally-visible statement with its appropriate user-language description; and supplying a user the at least one user-language description that is associated with the externally-visible statement.

Abstract: Novel BNP variants. The novel BNP variants according to the present invention may optionally be used for diagnosis of a BNP variant-detectable disease as described herein.

Abstract: A cellular telephone IC includes a baseband processing module, an RF section, an audio codec, a keypad interface, a memory interface, and a display interface. The baseband processing module and RF section function to convert an outbound voice signal into an outbound RF voice signal, to convert an inbound RF voice signal into an inbound voice signal, to convert outbound data into an outbound RF data signal, and to convert an inbound RF data signal into inbound data. The audio codec section converts inbound analog voice signals into the inbound voice signals and converts the outbound voice signals into outbound analog voice signals. The keypad interface produces the outbound data based on received inputs. The display interface provides the inbound data to an off-chip display.

Abstract: A communication device includes a voice data and RF integrated circuit (IC) that includes a memory module that stores a least one application as a plurality of operational instructions, the at least one application having a plurality of power modes that each correspond to one of a plurality of use characteristics. A processing module executes the plurality of operational instructions and determines a selected one of the plurality of power modes based on current use characteristics of the at least one application, and the generates a power mode signal based on the selected one of the plurality of power modes. An off-chip power management circuit receives the power mode signal and that generates a plurality of power supply signals to the voice data and RF IC based on the power mode signal.

Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.

Abstract: Novel BNP variants. The novel BNP variants according to the present invention may optionally be used for diagnosis of a BNP variant-detectable disease as described herein.

Abstract: A method of identifying alternatively spliced exons is provided. The method comprising, scoring each of a plurality of exon sequences derived from genes of a species according to at least one sequence parameter, wherein exon sequences of the plurality of exon sequences scoring above a predetermined threshold represent alternatively spliced exons, thereby identifying the alternatively spliced exons.

Abstract: One or more methods and systems of providing a conditioned power source to an external card that is communicatively connected to a host computing device by way of an external card adaptor are presented. The system and method facilitates the use of an external card having a connector that is incompatible with a PC card connector provided by the host computing device. In one or more embodiments, the external card adaptor performs power conditioning and/or voltage conversions of one or more power signal inputs provided by the host computing device. The power conditioning is performed using a power conditioning circuitry while the voltage conversions are performed using a voltage conversion circuitry.

Abstract: Novel markers for colon cancer that are both sensitive and accurate. These markers are overexpressed in colon cancer specifically, as opposed to normal colon tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of colon cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between colon cancer and non-cancerous states.

Abstract: Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.

Abstract: Novel alpha 1 subunit splice variants, including nucleic and amino acid sequences. Methods of use thereof are also described.